Project Grant R01NS147445
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $656,879 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. This award supports research investigating the mechanisms of glioma initiation driven by isocitrate dehydrogenase (IDH) oncogenes. The research...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through July 31, 2027. This high-risk, high-reward research initiative aims to develop innovative therapeutic strategies for spinal cord injury (SCI) by converting...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $249,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of February 15, 2026, and completion date of January 31, 2028. This research initiative focuses on developing gene replacement therapy using adeno-associated virus...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $637,820 to the Research Institute at Nationwide Children's Hospital on June 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project grant supports forward genetic analysis research designed to identify novel genes influencing forebrain neurodevelopment, with specific emphasis on cortical structure, lamination, and...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $513,535 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026, through May 31, 2030. The award supports structure-guided discovery research aimed at developing potent small molecule positive allosteric modulators (PAMs) for...
- Federal Project Grant Award Summary Baylor College of Medicine received a $370,462 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of June 3, 2025, and completion date of May 31, 2027. This grant supports the development of technical capabilities and research infrastructure to enable comparative neuroscience studies of...
- Summary of Federal Project Grant Award The National Institute of Neurological Disorders and Stroke (NINDS) awarded New York Institute of Technology $459,000 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective July 12, 2025, through June 30, 2028, funds a three-year research project investigating the anatomy and physiology of molecular layer heterotopia (MLH), a neuronal migration defect characterized by misplaced...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $156,760 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2026, through April 30, 2027. This research initiative investigates the catalytic potential of three rare disease-associated pseudokinases—SCYL1, SCYL2, and TBCK—which have...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $597,934 (awarded March 22, 2026, with completion targeted December 31, 2030) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, "Dissecting the Network Physiology of Pallidal Burst Stimulation," will advance...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $429,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of September 22, 2025, and completion date of August 31, 2027. This research project investigates the pathogenic mechanisms of prion diseases, specifically...
The University of Texas Southwestern Medical Center received a $655,557 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 4, 2026, through February 28, 2031. This award supports research utilizing interspecies blastocyst complementation (IBC), a novel technique that introduces donor pluripotent stem cells into host blastocysts to generate donor-cell-enriched organs within host organisms. The research specifically focuses on developing rat forebrain tissue in mice using a CRISPR-based blastocyst complementation method, enabling investigations into brain development and evolution from a xenogeneic perspective. The project deliverables encompass three primary research objectives: (1) elucidating xenogeneic barriers affecting brain development between mice and rats by investigating cell competition, proliferation differences, and cell adhesion incompatibility; (2) exploring non-cell autonomous mechanisms through multi-omics analyses to understand how rat-mouse chimeras adapt brain size and developmental pace; and (3) expanding complementation studies to wild rodent species, specifically attempting to generate forebrain tissues from African pygmy mice in mice hosts. These research activities will advance fundamental understanding of brain development and evolution while establishing ethical foundations for potential future applications of human pluripotent stem cells in animal brain research.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $655.6k | 5/5/26 |